Non-infected babies born to HIV mothers have reduced immunity to measles

October 18, 2012

Non-infected babies born to HIV positive mothers should be vaccinated early against measles, to avoid them acquiring the virus or passing it on to others.

A study published in the November issue of Acta Paediatrica found that even if babies are born without HIV, their maternally derived protection against measles may be impaired by their mother's positive .

"The eradication of measles is high on the agendas of the and other international agencies and it is important to define and target any new group of susceptible infants" says Dr Lars Smedman from the Department of Paediatrics at Karolinska University Hospital, Stockholm, Sweden.

According to the World Health Organization, measles is one of the leading causes of death among young children. Complications of this highly contagious, serious disease can include , blindness, destructive ear infections, severe diarrhoea and related dehydration.

In 2010 there were 139,300 deaths globally, which equates to 380 a day or 15 an hour. However, in 1980, before widespread immunisation, measles caused an estimated 2.6 million deaths a year. Immunisations have risen by 72% since 2000 and in 2010 about 85 per cent of the World's children received one dose of the by their first birthday.

Dr Smedman and colleagues compared samples from ten babies aged one to four months who were born to HIV mothers, but had not acquired the infection, to ten healthy babies born to mothers without HIV.

The mothers ranged from 26 to 35 years of age, were all immigrants and originated from Ethiopia, the Ivory Coast, Uganda, Kenya and Thailand. Their ranged from less than 20 to 8,870 and their CD4 cell counts from 237 to 754.

Nine gave birth by planned or emergency caesarean, with only one , and the of the babies ranged from 32 to 41 weeks.

"We used a new cell ELISA technique to demonstrate how the serum samples drawn from the infants would inactivate the measles virus" explains Dr Smedman.

"This found statistically significant differences between the maternal antibodies received by the two sets of babies and showed that the non-infected babies born to HIV positive mothers had weaker protection. This was because the antibodies normally produced by the mother to help protect her baby from measles had lost their sharp edge due to her HIV positive status.

"The results suggest that babies born to HIV mothers would not be able to neutralise the measles virus as effectively and would loose protection sooner than babies born to healthy mothers. These babies would therefore be much more likely to succumb to measles and, or, pass the virus on to other children, making their early immunisation vital."

Explore further: South Africa reports new success in saving newborns from HIV

More information: onlinelibrary.wiley.com/doi/10 … 012.02793.x/abstract

Related Stories

South Africa reports new success in saving newborns from HIV

July 19, 2012
About 117,000 babies were saved from HIV infection last year under South Africa's scheme to prevent mothers from passing on the disease during childbirth, health official said Thursday.

Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission

June 20, 2012
Non-breastfed babies born to HIV-positive mothers who didn't receive antiretroviral therapy during pregnancy are routinely given zidovudine, commonly known as AZT, shortly after birth to prevent mother-to-child transmission ...

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.